The Evaluation of Efficacy and Safety of Subsequent Cisplatin and Docetaxel Regimen In The First Line Treatment of Advanced Epithelial Ovarian Cancer.
Phase of Trial: Phase II
Latest Information Update: 30 Oct 2009
At a glance
- Drugs Cisplatin; Docetaxel
- Indications Ovarian cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms Tax-Over
- 14 Nov 2008 New trial record.